arrow
M

María Asunción García-González

centro de investigación biomédica en red en enfermedades digestivas y hepáticas (ciberehd)
H指数:26
被引数:1,968

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic value of neutrophil-to-lymphocyte; platelet-to-lymphocyte; and lymphocyte-to-monocyte ratios for assessing organ and multiorgan involvement in sarcoidosis: a retrospective single-center study

中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和淋巴细胞与单核细胞比值在评估结节病器官及多器官受累中的诊断价值:一项回顾性单中心研究

2026-03-130
OAAI
Exome sequencing points to pathogenic ATM variants in gastric cancer

外显子测序指向胃癌中的致病性ATM变异。

2025-12-260
OAAI
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
2024-05-251
OAAI
Acute Hypoxemic Respiratory Failure in Children at the Start of COVID-19 Outbreak: A Nationwide Experience

新型冠状病毒肺炎暴发开始时儿童的急性低氧性呼吸衰竭: 全国范围的经验

2021-09-221
OAAI
Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease

PSCA rs2294008基因变异与预后不良,胃癌易感性增加和十二指肠溃疡风险降低的关联

2015-03-1937
OA
Changes in Phosphorylation Status at VEGFR2 and Basal Tumor Hypoxic Volume Assessed by Misonidazol (MISO) Positron Emission Tomography (PET/CT) as Potential Biomarkers for Predicting Response to Bevacizumab in Breast Cancer.
2011-12-010
PRE
Use of Dynamic Contrast-Enhanced MR Imaging To Predict Pathological Response in Primary Breast Cancer.
2011-12-010
PRE
Predicting Response to Bevacizumab in Primary Breast Cancer Using 18F-Fluorothymidina (FLT) and 18F-Misonidazole (MISO) Positron Emission/Computed Tomography (PET/CT) as Imaging Biomarkers
2011-12-010
PRE